• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种在神经退行性疾病中节省时间和能量的运动神经元策略:适应性蛋白质化学计量。

A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.

机构信息

Centre for Neuroscience and Trauma, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Center of Genomic and post-Genomic, IRCCS Mondino Foundation, Pavia, Italy.

出版信息

J Neurochem. 2018 Sep;146(5):631-641. doi: 10.1111/jnc.14542.

DOI:10.1111/jnc.14542
PMID:29959860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6175430/
Abstract

Neurofilament proteins (Nf) are a biomarker of disease progression in amyotrophic lateral sclerosis (ALS). This study investigated whether there are major differences in expression from in vivo measurements of neurofilament isoforms, from the light chain, NfL (68 kDa), compared with larger proteins, the medium chain (NfM, 150 kDa) and the heavy (NfH, 200-210 kDa) chains in ALS patients and healthy controls. New immunological methods were combined with Nf subunit stoichiometry calculations and Monte Carlo simulations of a coarse-grained Nf brush model. Based on a physiological Nf subunit stoichiometry of 7 : 3 : 2 (NfL:NfM:NfH), we found an 'adaptive' Nf subunit stoichiometry of 24 : 2.4 : 1.6 in ALS. Adaptive Nf stoichiometry preserved NfL gyration radius in the Nf brush model. The energy and time requirements for Nf translation were 56 ± 27k ATP (5.6 h) in control subjects compared to 123 ± 102k (12.3 h) in ALS with 'adaptive' (24:2.4:1.6) Nf stoichiometry (not significant) and increased significantly to 355 ± 330k (35.5 h) with 'luxury' (7:3:2) Nf subunit stoichiometry (p < 0.0001 for each comparison). Longitudinal disease progression-related energy consumption was highest with a 'luxury' (7:3:2) Nf stoichiometry. Therefore, an energy and time-saving option for motor neurons is to shift protein expression from larger to smaller (cheaper) subunits, at little or no costs on a protein structural level, to compensate for increased energy demands.

摘要

神经丝蛋白(Nf)是肌萎缩侧索硬化症(ALS)疾病进展的生物标志物。本研究旨在探讨 ALS 患者与健康对照组相比,神经丝同工型的活体测量中,轻链 NfL(68 kDa)与较大蛋白(NfM,150 kDa 和 NfH,200-210 kDa)之间的表达是否存在显著差异。研究结合了新的免疫方法和神经丝亚基化学计量计算以及粗粒度神经丝刷模型的蒙特卡罗模拟。基于生理神经丝亚基化学计量比 7:3:2(NfL:NfM:NfH),我们发现 ALS 中的“适应性”神经丝亚基化学计量比为 24:2.4:1.6。适应性神经丝化学计量比在神经丝刷模型中保持了 NfL 的旋转半径。在对照组中,神经丝翻译的能量和时间需求分别为 56±27k ATP(5.6 小时),而 ALS 患者中具有“适应性”(24:2.4:1.6)神经丝化学计量比的能量和时间需求分别为 123±102k(12.3 小时)(无显著差异),而具有“奢侈”(7:3:2)神经丝亚基化学计量比的能量和时间需求则显著增加至 355±330k(35.5 小时)(p 值均<0.0001)。具有“奢侈”(7:3:2)神经丝化学计量比的情况下,与疾病进展相关的能量消耗最高。因此,运动神经元的一种节能和省时的选择是将蛋白表达从较大的亚基转移到较小的(更便宜的)亚基,在蛋白结构水平上几乎没有或没有任何成本,以补偿能量需求的增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/5ea9e7159c95/JNC-146-631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/765eb0244d37/JNC-146-631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/ef2ef8b08f75/JNC-146-631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/5ea9e7159c95/JNC-146-631-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/765eb0244d37/JNC-146-631-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/ef2ef8b08f75/JNC-146-631-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a41/6175430/5ea9e7159c95/JNC-146-631-g003.jpg

相似文献

1
A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.一种在神经退行性疾病中节省时间和能量的运动神经元策略:适应性蛋白质化学计量。
J Neurochem. 2018 Sep;146(5):631-641. doi: 10.1111/jnc.14542.
2
Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.血清神经丝轻链水平作为肌萎缩侧索硬化症患者上运动神经元退变的标志物。
Neuropathol Appl Neurobiol. 2019 Apr;45(3):291-304. doi: 10.1111/nan.12511. Epub 2018 Jul 18.
3
Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure.神经丝化学计量模拟在神经退行性变过程中表明了一种显著的自给自足和稳定的体内蛋白质结构。
J Neurol Sci. 2011 Aug 15;307(1-2):132-8. doi: 10.1016/j.jns.2011.04.023. Epub 2011 May 23.
4
Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS).散发性肌萎缩侧索硬化症(ALS)患者颈段脊髓运动神经元中神经元中间丝蛋白表达的特征分析
J Neuropathol Exp Neurol. 2000 Nov;59(11):972-82. doi: 10.1093/jnen/59.11.972.
5
Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.脑脊液神经丝在运动神经元病患者队列中的诊断和预后价值:一项横断面研究。
J Cell Mol Med. 2021 Apr;25(8):3765-3771. doi: 10.1111/jcmm.16240. Epub 2021 Feb 20.
6
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.血浆神经丝重链水平与肌萎缩侧索硬化症的疾病进展:一项纵向研究的见解
J Neurol Neurosurg Psychiatry. 2015 May;86(5):565-73. doi: 10.1136/jnnp-2014-307672. Epub 2014 Jul 9.
7
Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脊髓运动神经元中神经丝重链亚基聚集的定量证据。
Braz J Med Biol Res. 2005 Jun;38(6):925-33. doi: 10.1590/s0100-879x2005000600015. Epub 2005 Jun 1.
8
Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).43kDa 焦油 DNA 结合蛋白(TDP-43)、14-3-3 蛋白和铜/锌超氧化物歧化酶(SOD1)相互作用调节 NFL mRNA 的稳定性。对肌萎缩侧索硬化症(ALS)中改变的 RNA 处理的影响。
Brain Res. 2009 Dec 11;1305:168-82. doi: 10.1016/j.brainres.2009.09.105. Epub 2009 Oct 6.
9
Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs.ALS 相关 miRNA 对人 NEFM 和 NEFH mRNA 稳定性的调控。
Mol Brain. 2018 Jul 20;11(1):43. doi: 10.1186/s13041-018-0386-3.
10
Neurofilament metabolism in sporadic amyotrophic lateral sclerosis.散发性肌萎缩侧索硬化症中的神经丝代谢
J Neurol Sci. 1999 Oct 31;169(1-2):170-7. doi: 10.1016/s0022-510x(99)00241-5.

引用本文的文献

1
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications.肌萎缩侧索硬化症中的新兴生物标志物:从发病机制到临床应用
Front Mol Biosci. 2025 Jun 30;12:1608853. doi: 10.3389/fmolb.2025.1608853. eCollection 2025.
2
SOD1, A Crucial Protein for Neural Biochemistry: Dysfunction and Risk of Amyotrophic Lateral Sclerosis.超氧化物歧化酶1,一种神经生物化学的关键蛋白质:功能障碍与肌萎缩侧索硬化症风险
Mol Neurobiol. 2025 May 26. doi: 10.1007/s12035-025-05067-1.
3
CK and LRRK2 Involvement in Neurodegenerative Diseases.

本文引用的文献

1
Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中嗜铬粒蛋白 A 水平。
Neurobiol Aging. 2018 Jul;67:21-22. doi: 10.1016/j.neurobiolaging.2018.02.017. Epub 2018 Feb 27.
2
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的脑脊液巨噬细胞生物标志物。
Ann Neurol. 2018 Feb;83(2):258-268. doi: 10.1002/ana.25143. Epub 2018 Feb 9.
3
CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
CK 和 LRRK2 参与神经退行性疾病。
Int J Mol Sci. 2024 Oct 30;25(21):11661. doi: 10.3390/ijms252111661.
4
Neurofilament Isoform Promoter-Driven Expression of Therapeutic Genes.神经丝蛋白异构体启动子驱动的治疗性基因表达。
Transl Vis Sci Technol. 2024 Sep 3;13(9):30. doi: 10.1167/tvst.13.9.30.
5
Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.散发性和家族性肌萎缩侧索硬化症中的神经丝:系统评价与荟萃分析
Genes (Basel). 2024 Apr 16;15(4):496. doi: 10.3390/genes15040496.
6
Neurofilaments as biomarkers in neurological disorders - towards clinical application.神经丝作为神经紊乱的生物标志物——迈向临床应用。
Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12.
7
Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy.研究血清神经丝轻链水平作为小纤维神经病变潜在的新型生物标志物。
Eur J Neurol. 2024 Apr;31(4):e16192. doi: 10.1111/ene.16192. Epub 2024 Jan 8.
8
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects.肌萎缩侧索硬化症中的生物标志物:现状与未来展望。
Nat Rev Neurol. 2023 Dec;19(12):754-768. doi: 10.1038/s41582-023-00891-2. Epub 2023 Nov 10.
9
Blood biomarkers in ALS: challenges, applications and novel frontiers.肌萎缩侧索硬化症中的血液生物标志物:挑战、应用及新前沿。
Acta Neurol Scand. 2022 Oct;146(4):375-388. doi: 10.1111/ane.13698.
10
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset.内含子 NEFH 变异与散发型 ALS 风险降低和疾病发病年龄较晚相关。
Sci Rep. 2022 Aug 30;12(1):14739. doi: 10.1038/s41598-022-18942-x.
脑脊液神经丝蛋白作为肌萎缩侧索硬化症的诊断和预后生物标志物。
J Neurol. 2018 Mar;265(3):510-521. doi: 10.1007/s00415-017-8730-6. Epub 2018 Jan 10.
4
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.多中心研究在肌萎缩侧索硬化症早期症状发作时的神经丝。
Neurology. 2018 Jan 2;90(1):e22-e30. doi: 10.1212/WNL.0000000000004761. Epub 2017 Dec 6.
5
Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.比较肌萎缩侧索硬化症患者血清和脑脊液中升高的磷酸化神经丝重链。
J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):367-373. doi: 10.1136/jnnp-2017-316605. Epub 2017 Oct 20.
6
Amyotrophic lateral sclerosis.肌萎缩侧索硬化症。
Nat Rev Dis Primers. 2017 Oct 5;3:17071. doi: 10.1038/nrdp.2017.71.
7
Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis.磷酸化神经丝重链:C9ORF72相关肌萎缩侧索硬化症生存的生物标志物。
Ann Neurol. 2017 Jul;82(1):139-146. doi: 10.1002/ana.24980.
8
Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.肌萎缩侧索硬化症的神经丝标志物与上下运动神经元疾病的程度相关。
Neurology. 2017 Jun 13;88(24):2302-2309. doi: 10.1212/WNL.0000000000004029. Epub 2017 May 12.
9
NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration.在一种可诱导的神经退行性变小鼠模型中,脑脊液和血清中的神经丝轻链是神经元损伤的生物标志物。
Neurobiol Dis. 2017 Aug;104:73-84. doi: 10.1016/j.nbd.2017.04.007. Epub 2017 Apr 6.
10
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.肌萎缩侧索硬化症的诊断和预后生物标志物:疾病明确亚型中的神经丝轻链水平
JAMA Neurol. 2017 May 1;74(5):525-532. doi: 10.1001/jamaneurol.2016.5398.